Product NDC: | 52584-870 |
Proprietary Name: | CLEOCIN PHOSPHATE |
Non Proprietary Name: | clindamycin phosphate |
Active Ingredient(s): | 150 mg/mL & nbsp; clindamycin phosphate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52584-870 |
Labeler Name: | General Injectables & Vaccines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050441 |
Marketing Category: | NDA |
Start Marketing Date: | 20121019 |
Package NDC: | 52584-870-21 |
Package Description: | 1 VIAL in 1 BAG (52584-870-21) > 2 mL in 1 VIAL |
NDC Code | 52584-870-21 |
Proprietary Name | CLEOCIN PHOSPHATE |
Package Description | 1 VIAL in 1 BAG (52584-870-21) > 2 mL in 1 VIAL |
Product NDC | 52584-870 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | clindamycin phosphate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20121019 |
Marketing Category Name | NDA |
Labeler Name | General Injectables & Vaccines, Inc |
Substance Name | CLINDAMYCIN PHOSPHATE |
Strength Number | 150 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |